https://www.selleckchem.com/pr....oducts/8-bromo-camp.
12 [1.03-4.37]; p=0.043) were associated with complete resolution. RPO was associated with recurrent PE as well as the combined endpoint consisting of recurrent VTE and/or CTEPH (4.67 [95% CI, 1.26-17.26]; p=0.02) and (OR 6.4 [95% CI, 1.9-21.2]; p0.005), respectively. Resolution of PE is associated with a lower risk of recurrent thrombosis. Earlier initiation of treatment improves prognosis as measured by resolution on follow-up CTA. Resolution of PE is associated with a lower risk of recurrent thrombosis. Earlier initiation of